B-intervention	0	12	Preoperative
I-intervention	13	16	MRI
O	17	19	of
O	20	23	the
O	24	30	breast
O	31	32	(
O	32	36	POMB
O	36	37	)
O	38	48	influences
O	49	56	primary
O	57	66	treatment
O	67	69	in
O	70	76	breast
O	77	83	cancer
O	83	84	:
O	85	86	a
O	87	98	prospective
O	98	99	,
O	100	110	randomized
O	110	111	,
O	112	123	multicenter
O	124	129	study
O	129	130	.

O	131	137	Breast
O	138	146	magnetic
O	147	156	resonance
O	157	164	imaging
O	165	166	(
O	166	169	MRI
O	169	170	)
O	171	174	has
O	175	180	shown
O	181	185	high
O	186	197	sensitivity
O	198	200	in
O	201	212	determining
O	213	218	tumor
O	219	225	extent
O	225	226	,
O	227	240	multifocality
O	240	241	,
O	242	245	and
O	246	252	occult
O	253	266	contralateral
O	267	273	breast
O	274	280	cancer
O	280	281	.

O	282	285	Low
O	286	297	specificity
O	297	298	,
O	299	310	unnecessary
O	311	323	mastectomies
O	323	324	,
O	325	328	and
O	329	334	costs
O	335	338	are
O	339	348	arguments
O	349	356	against
O	357	360	MRI
O	360	361	.

O	362	365	The
O	366	373	purpose
O	374	376	of
O	377	381	this
O	382	387	study
O	388	391	was
O	392	394	to
O	395	404	determine
O	405	412	whether
O	413	425	preoperative
O	426	432	breast
O	433	436	MRI
O	437	442	would
O	443	449	affect
O	450	457	primary
O	458	466	surgical
O	467	477	management
O	477	478	,
O	479	485	reduce
O	486	496	reexcision
O	496	497	/
O	497	508	reoperation
O	509	519	procedures
O	519	520	,
O	521	524	and
O	525	534	influence
O	535	538	the
O	539	545	choice
O	546	548	of
O	549	560	neoadjuvant
O	561	570	treatment
O	571	573	in
O	574	582	patients
O	583	587	with
O	588	593	newly
O	594	603	diagnosed
O	604	610	breast
O	611	617	cancer
O	617	618	.

O	619	623	This
O	624	635	prospective
O	635	636	,
O	637	647	randomized
O	647	648	,
O	649	660	multicenter
O	661	666	study
O	667	675	included
B-total-participants	676	679	440
O	680	686	breast
O	687	693	cancer
O	694	702	patients
O	703	710	younger
O	711	715	than
O	716	720	aged
B-age	721	723	56
I-age	724	729	years
O	730	734	from
O	735	740	three
O	740	741	,
B-location	742	749	Swedish
O	749	750	,
O	751	756	large
O	756	757	-
O	757	763	volume
O	764	770	breast
O	771	776	units
O	776	777	.

O	778	786	Patients
O	787	791	were
O	792	800	randomly
O	801	810	allocated
O	811	813	on
O	814	815	a
O	816	817	1
O	817	818	:
O	818	819	1
O	820	825	basis
O	826	828	to
O	829	835	either
O	836	848	preoperative
O	849	856	staging
O	857	861	with
O	862	868	breast
O	869	872	MRI
O	873	874	(
O	874	875	n
O	876	877	=
B-intervention-participants	878	881	220
O	881	882	)
O	883	885	or
B-control	886	888	no
I-control	889	895	breast
I-control	896	899	MRI
O	900	901	(
O	901	902	n
O	903	904	=
B-control-participants	905	908	220
O	908	909	)
O	910	911	(
O	911	918	control
O	919	924	group
O	924	925	)
O	925	926	.

O	927	936	Treatment
O	937	945	planning
O	946	948	of
O	949	952	all
O	953	961	patients
O	962	965	was
O	966	975	discussed
O	976	978	at
O	979	996	multidisciplinary
O	997	1001	team
O	1002	1013	conferences
O	1013	1014	.

O	1015	1017	In
O	1018	1026	patients
O	1027	1037	randomized
O	1038	1040	to
O	1041	1044	the
O	1045	1048	MRI
O	1049	1054	group
O	1054	1055	,
O	1056	1059	who
O	1060	1063	had
O	1064	1066	an
O	1067	1075	observed
O	1076	1082	higher
O	1083	1093	percentage
O	1094	1096	of
O	1097	1104	planned
O	1105	1111	breast
O	1111	1112	-
O	1112	1122	conserving
O	1123	1130	surgery
O	1131	1132	(
O	1132	1135	BCS
O	1135	1136	)
O	1137	1145	compared
O	1146	1150	with
O	1151	1154	the
O	1155	1162	control
O	1163	1168	group
O	1168	1169	,
O	1170	1171	a
B-outcome	1172	1178	change
I-outcome	1179	1183	from
I-outcome	1184	1193	suggested
I-outcome	1194	1200	breast
I-outcome	1201	1213	conservation
I-outcome	1214	1216	to
I-outcome	1217	1227	mastectomy
O	1228	1236	occurred
O	1237	1239	in
B-iv-bin-abs	1240	1242	23
O	1243	1245	of
B-intervention-participants	1246	1249	153
O	1250	1251	(
B-iv-bin-percent	1251	1253	15
I-iv-bin-percent	1254	1255	%
O	1255	1256	)
O	1257	1265	patients
O	1265	1266	.

O	1267	1273	Breast
O	1274	1277	MRI
O	1278	1286	provided
O	1287	1297	additional
O	1298	1309	information
O	1310	1312	in
O	1313	1315	83
O	1316	1318	of
O	1319	1322	220
O	1323	1324	(
O	1324	1326	38
O	1327	1328	%
O	1328	1329	)
O	1330	1338	patients
O	1338	1339	,
O	1340	1345	which
O	1346	1352	caused
O	1353	1354	a
B-outcome	1355	1361	change
I-outcome	1362	1364	in
I-outcome	1365	1374	treatment
I-outcome	1375	1379	plan
O	1380	1382	in
B-iv-bin-abs	1383	1385	40
O	1386	1387	(
B-iv-bin-percent	1387	1389	18
I-iv-bin-percent	1390	1391	%
O	1391	1392	)
O	1392	1393	.

O	1394	1397	The
B-outcome	1398	1404	breast
I-outcome	1405	1416	reoperation
I-outcome	1417	1421	rate
O	1422	1425	was
O	1426	1439	significantly
O	1440	1445	lower
O	1446	1448	in
O	1449	1452	the
O	1453	1456	MRI
O	1457	1462	group
O	1462	1463	:
B-iv-bin-abs	1464	1466	11
O	1467	1469	of
B-intervention-participants	1470	1473	220
O	1474	1475	(
B-iv-bin-percent	1475	1476	5
I-iv-bin-percent	1477	1478	%
O	1478	1479	)
O	1480	1486	versus
B-cv-bin-abs	1487	1489	33
O	1490	1492	of
B-control-participants	1493	1496	220
O	1497	1498	(
B-cv-bin-percent	1498	1500	15
I-cv-bin-percent	1501	1502	%
O	1502	1503	)
O	1504	1506	in
O	1507	1510	the
O	1511	1518	control
O	1519	1524	group
O	1525	1526	(
O	1526	1527	p
O	1528	1529	<
O	1530	1531	0
O	1531	1532	.
O	1532	1535	001
O	1535	1536	)
O	1536	1537	.

O	1538	1541	The
B-outcome	1542	1548	number
I-outcome	1549	1551	of
I-outcome	1552	1564	mastectomies
O	1564	1565	,
B-outcome	1566	1574	axillary
I-outcome	1575	1587	reoperations
O	1587	1588	,
O	1589	1592	and
O	1593	1596	the
B-outcome	1597	1603	number
I-outcome	1604	1606	of
I-outcome	1607	1615	patients
I-outcome	1616	1625	receiving
I-outcome	1626	1637	neoadjuvant
I-outcome	1638	1650	chemotherapy
O	1651	1656	after
O	1657	1667	definitive
O	1668	1677	treatment
O	1678	1681	did
O	1682	1685	not
O	1686	1692	differ
O	1693	1706	significantly
O	1707	1714	between
O	1715	1718	the
O	1719	1725	groups
O	1725	1726	.

O	1727	1739	Preoperative
O	1740	1747	staging
O	1748	1752	with
O	1753	1759	breast
O	1760	1763	MRI
O	1764	1766	in
O	1767	1772	women
O	1773	1780	younger
O	1781	1785	than
O	1786	1789	age
O	1790	1792	56
O	1793	1798	years
B-outcome	1799	1806	altered
I-outcome	1807	1810	the
I-outcome	1811	1820	treatment
I-outcome	1821	1825	plan
O	1826	1828	in
O	1829	1831	18
O	1832	1833	%
O	1834	1836	of
O	1837	1840	the
O	1841	1849	patients
O	1849	1850	.

O	1851	1859	Although
O	1860	1861	a
O	1862	1868	higher
O	1869	1872	MRI
O	1872	1873	-
O	1873	1880	related
O	1881	1891	conversion
O	1892	1896	rate
O	1897	1901	from
O	1902	1908	breast
O	1909	1921	conservation
O	1922	1924	to
O	1925	1935	mastectomy
O	1936	1939	was
O	1940	1945	found
O	1945	1946	,
O	1947	1950	the
O	1951	1956	final
O	1957	1964	numbers
O	1965	1967	of
O	1968	1980	mastectomies
O	1981	1984	did
O	1985	1988	not
O	1989	1995	differ
O	1996	2003	between
O	2004	2007	the
O	2008	2011	two
O	2012	2018	groups
O	2018	2019	.

O	2020	2023	The
O	2024	2030	breast
O	2031	2042	reoperation
O	2043	2047	rate
O	2048	2050	in
O	2051	2054	the
O	2055	2058	MRI
O	2059	2064	group
O	2065	2068	was
O	2069	2082	significantly
O	2083	2090	reduced
O	2090	2091	.
